These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29798942)

  • 21. Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
    Wang Y; Liao X; Ye Q; Huang L
    Sci China Life Sci; 2018 Nov; 61(11):1389-1395. PubMed ID: 30076562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
    Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
    [No Abstract]   [Full Text] [Related]  

  • 23. MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
    Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
    Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
    Shi M; Wang Z; Liu XY; Chen D
    Med Oncol; 2014 Dec; 31(12):309. PubMed ID: 25391920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-1291 targets mucin 1 inhibiting cell proliferation and invasion to promote cell apoptosis in esophageal squamous cell carcinoma.
    Luo H; Guo W; Wang F; You Y; Wang J; Chen X; Wang J; Wang Y; Du Y; Chen X; Xue C; Song G; Wang F
    Oncol Rep; 2015 Nov; 34(5):2665-73. PubMed ID: 26324125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors and outcome for patients with esophageal squamous cell carcinoma underwent surgical resection alone: evaluation of the seventh edition of the American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Yang JS; Yang WP; Liu DT; Chen YP; Zhang H
    J Thorac Oncol; 2013 Apr; 8(4):495-501. PubMed ID: 23446203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Mori Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Mori R; Tomoda K; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2007 Oct; 18(4):981-5. PubMed ID: 17786363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific MUC1 splice variants are correlated with tumor progression in esophageal cancer.
    Kahkhaie KR; Moaven O; Abbaszadegan MR; Montazer M; Gholamin M
    World J Surg; 2014 Aug; 38(8):2052-7. PubMed ID: 24718884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
    Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
    Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.
    Chen J; Wen J; Zheng Y; Yang H; Luo K; Liu Q; Hu R; Tan Z; Huang Q; Fu J
    Tumour Biol; 2015 Sep; 36(9):6797-803. PubMed ID: 25835977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Wang JH; Chen XT; Wen ZS; Zheng M; Deng JM; Wang MZ; Lin HX; Chen K; Li J; Yun JP; Luo RZ; Song LB
    PLoS One; 2012; 7(10):e45622. PubMed ID: 23056210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy.
    Sato Y; Motoyama S; Wakita A; Kawakita Y; Liu J; Nagaki Y; Nanjo H; Terata K; Imai K; Saito H; Minamiya Y
    Am J Surg; 2018 Aug; 216(2):319-325. PubMed ID: 29395019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
    Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
    Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
    Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
    Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.